Grabowski J - Search Results

1

Prognostic significance of Ki-67 levels and hormone receptor expression in low-grade serous ovarian carcinoma: an investigation of the Tumor Bank Ovarian Cancer Network.

Sehouli J, Braicu EI, Richter R, Denkert C, Jank P, Jurmeister PS, Kunze CA, Budczies J, Darb-Esfahani S, Schmitt WD, Traut A, Grabowski J, Taube ET, Plett H. Sehouli J, et al. Among authors: grabowski j. Hum Pathol. 2019 Mar;85:299-308. doi: 10.1016/j.humpath.2018.10.020. Epub 2018 Nov 11. Hum Pathol. 2019. PMID: 30428389

2

Incidence and Pattern of Spread of Lymph Node Metastasis in Patients With Low-grade Serous Ovarian Cancer.

Wafa M, Braicu EI, Muallem MZ, Richter R, Taube E, Sehouli J, Grabowski JP. Wafa M, et al. Among authors: grabowski jp. Anticancer Res. 2019 Oct;39(10):5617-5621. doi: 10.21873/anticanres.13757. Anticancer Res. 2019. PMID: 31570458

3

Surgery in recurrent ovarian cancer.

Sehouli J, Grabowski JP. Sehouli J, et al. Among authors: grabowski jp. Cancer. 2019 Dec 15;125 Suppl 24:4598-4601. doi: 10.1002/cncr.32511. Cancer. 2019. PMID: 31967681 Free article. Review.

4

Ki67 expression as a predictor of chemotherapy outcome in low-grade serous ovarian cancer.

Grabowski JP, Martinez Vila C, Richter R, Taube E, Plett H, Braicu E, Sehouli J. Grabowski JP, et al. Int J Gynecol Cancer. 2020 Apr;30(4):498-503. doi: 10.1136/ijgc-2019-000976. Epub 2020 Jan 28. Int J Gynecol Cancer. 2020. PMID: 31996397

5

Lymphovascular space invasion and Ki67 as predictors of lymph node metastasis in primary low grade serous ovarian cancer.

Grabowski JP, Glajzer J, Richter R, Plett H, Muallem MZ, Braicu EI, Taube E, Sehouli J. Grabowski JP, et al. Int J Gynecol Cancer. 2021 Jan;31(1):98-103. doi: 10.1136/ijgc-2020-001950. Epub 2020 Oct 30. Int J Gynecol Cancer. 2021. PMID: 33127866

6

Impact of Body Mass Index (BMI) on Chemotherapy-associated Toxicity in Ovarian Cancer Patients. A Pooled Analysis of the North-Eastern German Society of Gynecological Oncology (NOGGO) Databank on 1,213 Patients.

Grabowski JP, Richter R, Rittmeister H, Chekerov R, Woopen H, Sehouli J. Grabowski JP, et al. Anticancer Res. 2018 Oct;38(10):5853-5858. doi: 10.21873/anticanres.12927. Anticancer Res. 2018. PMID: 30275210

7

Current management of ovarian cancer.

Grabowski JP, Sehouli J. Grabowski JP, et al. Minerva Med. 2015 Jun;106(3):151-6. Epub 2015 Apr 22. Minerva Med. 2015. PMID: 25900837 Review.

8

Surgery for recurrent ovarian cancer: Options and limits.

Sehouli J, Grabowski JP. Sehouli J, et al. Among authors: grabowski jp. Best Pract Res Clin Obstet Gynaecol. 2017 May;41:88-95. doi: 10.1016/j.bpobgyn.2016.10.009. Epub 2016 Oct 21. Best Pract Res Clin Obstet Gynaecol. 2017. PMID: 27865654 Review.

9

Survival and prognostic factors in patients with recurrent low-grade epithelial ovarian cancer: An analysis of five prospective phase II/III trials of NOGGO metadata base.

Canaz E, Grabowski JP, Richter R, Braicu EI, Chekerov R, Sehouli J. Canaz E, et al. Among authors: grabowski jp. Gynecol Oncol. 2019 Sep;154(3):539-546. doi: 10.1016/j.ygyno.2019.06.014. Epub 2019 Jun 21. Gynecol Oncol. 2019. PMID: 31230821

10

Clinical Outcome After Completion Surgery in Patients With Ovarian Cancer: The Charite Experience.

Babayeva A, Braicu EI, Grabowski JP, Gasimli K, Richter R, Muallem MZ, Sehouli J. Babayeva A, et al. Among authors: grabowski jp. Int J Gynecol Cancer. 2018 Oct;28(8):1491-1497. doi: 10.1097/IGC.0000000000001328. Int J Gynecol Cancer. 2018. PMID: 30095708

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

522 results

Search Page

Filters